Claude Nicaise - Mar 7, 2022 Form 4 Insider Report for Chemomab Therapeutics Ltd. (CMMB)

Role
Director
Signature
/s/ Matthew Rudolph, Esq., Attorney-in-Fact for Claude Nicaise
Stock symbol
CMMB
Transactions as of
Mar 7, 2022
Transactions value $
$0
Form type
4
Date filed
3/9/2022, 03:07 PM
Next filing
Sep 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMMB Option to Purchase American Depositary Shares Award $0 +6.82K $0.00 6.82K Mar 7, 2022 American Depositary Shares 6.82K $3.53 Direct F1, F2
transaction CMMB Option to Purchase American Depositary Shares Award $0 +11.9K $0.00 11.9K Apr 19, 2021 American Depositary Shares 11.9K $27.26 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest and become exercisable in their entirety on March 16, 2023.
F2 Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F3 No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
F4 These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.